World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
66542
World Ranking
5664
National Ranking
224

Overview

Torsten O. Nielsen is affiliated with the University of British Columbia in Canada. Their research primarily spans the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with a strong focus on Oncology and Cancer Research.

The subfields of study where Nielsen has contributed include Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, and Radiology, Nuclear Medicine, and Imaging.

They have published extensively on topics related to:

  • Breast Cancer Treatment Studies
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Sarcoma Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • HER2/EGFR in Cancer Research
  • Cancer Cells and Metastasis

Their recent notable papers include:

  • Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group (2020), published in JNCI Journal of the National Cancer Institute
  • The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice (2020), published in The Journal of Pathology
  • The epigenomics of sarcoma (2020), published in Nature reviews. Cancer
  • Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer (2020), published in npj Breast Cancer
  • Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas (2020), published in OncoImmunology

Frequent collaborators in Nielsen's work include:

  • Samuel Leung
  • Dongxia Gao
  • Karama Asleh
  • Zuzana Kos
  • Anne-Vibeke Lænkholm

Their publications have appeared in various venues, with multiple contributions to:

  • UNC Libraries
  • npj Breast Cancer
  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Clinical Oncology

Best Publications

  • Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

    Joel S. Parker;Michael Mullins;Maggie C.U. Cheang;Samuel Leung

  • Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

    Lisa A. Carey;Charles M. Perou;Chad A. Livasy;Lynn G. Dressler

  • Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

    Torsten O. Nielsen;Forrest D. Hsu;Kristin Jensen;Maggie Cheang

  • The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

    R. Salgado;C. Denkert;S. Demaria;N. Sirtaine

  • Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

    Maggie C. U. Cheang;Stephen K Chia;David Voduc;Dongxia Gao

  • Metastatic Behavior of Breast Cancer Subtypes

    Hagen Kennecke;Rinat Yerushalmi;Ryan Woods;Maggie Chon U. Cheang

  • Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

    Mitch Dowsett;Torsten O. Nielsen;Roger A’Hern;John Bartlett

  • Breast Cancer Subtypes and the Risk of Local and Regional Relapse

    K. David Voduc;Maggie C.U. Cheang;Scott Tyldesley;Karen Gelmon

  • Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.

    Maggie C.U. Cheang;David Voduc;Chris Bajdik;Samuel Leung

  • Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

    Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks

  • Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group Part 2 TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer

    Torsten O Nielsen;Joel S Parker;Samuel Leung;K David Voduc

  • The Novel Marker, DOG1, Is Expressed Ubiquitously in Gastrointestinal Stromal Tumors Irrespective of KIT or PDGFRA Mutation Status

    Robert B. West;Christopher L Corless;Xin Chen;Brian P. Rubin

  • Systematic analysis of breast cancer morphology uncovers stromal features associated with survival.

    Andrew H. Beck;Ankur R. Sangoi;Ankur R. Sangoi;Samuel Leung;Robert J. Marinelli

  • Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients

    Hamid Ali;E Provenzano;S-J Dawson;FM Blows

  • Molecular characterisation of soft tissue tumours: a gene expression study

    Torsten O Nielsen;Rob B West;Sabine C Linn;Orly Alter

  • Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

    Aleix Prat;Maggie Chon U. Cheang;Miguel Martín;Joel S. Parker

  • Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

    Judith Hugh;John Hanson;Maggie Chon U. Cheang;Torsten O. Nielsen

  • An International Ki67 Reproducibility Study

    Mei Yin C Polley;Samuel C Y Leung;Lisa M. McShane;Dongxia Gao

Frequent Co-Authors

Maggie C.U. Cheang
Maggie C.U. Cheang Institute of Cancer Research
Charles M. Perou
Charles M. Perou University of North Carolina at Chapel Hill
David G. Huntsman
David G. Huntsman University of British Columbia
Karen A. Gelmon
Karen A. Gelmon University of British Columbia
Matthew J. Ellis
Matthew J. Ellis Baylor College of Medicine
Matt van de Rijn
Matt van de Rijn Stanford University
C. Blake Gilks
C. Blake Gilks University of British Columbia
Roberto Salgado
Roberto Salgado Peter MacCallum Cancer Centre
Giuseppe Viale
Giuseppe Viale University of Milan
Elaine R. Mardis
Elaine R. Mardis The Ohio State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees and online programs can open new doors for those pursuing careers in medicine and related fields. Distance learning has made education more accessible, allowing students to balance studies with work or personal responsibilities.

For registered nurses seeking advanced credentials, the cheapest dnp program options offer a cost-effective route to earn a Doctor of Nursing Practice. Meanwhile, those aiming to become licensed quickly might consider the fastest lpn program to accelerate their entry into the nursing profession.

Mental health is another growing field, with various online msn pmhnp programs available for nurses who want to specialize as psychiatric mental health nurse practitioners. On the administrative side, earning an online health management degree prepares graduates for leadership and management roles within healthcare organizations.

Each of these pathways offers unique opportunities and challenges, making it important to research your options and choose a program aligned with your interests and career goals.

Best Scientists Citing Torsten O. Nielsen

Trending Scientists